Literature DB >> 14499196

DQAsome-mediated delivery of plasmid DNA toward mitochondria in living cells.

Gerard G M D'Souza1, Ram Rammohan, Shing-Ming Cheng, Vladimir P Torchilin, Volkmar Weissig.   

Abstract

DQAsomes are mitochondriotropic cationic 'bola-lipid'-based vesicles, which have been developed by us for the transport of drugs and DNA to mitochondria in living cells. This has made direct mitochondrial gene therapy feasible for the very first time. Our strategy for the delivery of DNA into the matrix of mitochondria is based upon the DQAsomal transport of a DNA-signal peptide conjugate to mitochondria, the selective liberation of this conjugate from DQAsomes at the mitochondrial membrane followed by DNA uptake via the mitochondrial protein import machinery. Using membrane-mimicking liposomes and isolated rat liver mitochondria we have shown earlier that DQAsome-DNA complexes (DQAplexes) selectively release pDNA when in contact with mitochondria-like membranes. Employing a newly developed protocol for selectively staining free pDNA in the cytosol of living cells and based on confocal fluorescence microscopic imaging we demonstrate here that DQAplexes appear to be able to escape from endosomes without loosing their pDNA load and transport the pDNA to the site of mitochondria at which at least a portion of the pDNA is released from its DQAsomal carrier. Free pDNA could not be detected anywhere else inside the cytosol of transfected cells demonstrating the target-selectivity of DQAsome-mediated DNA delivery to mitochondria.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14499196     DOI: 10.1016/s0168-3659(03)00297-9

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  33 in total

Review 1.  Mitochondrial medicine: to a new era of gene therapy for mitochondrial DNA mutations.

Authors:  Hélène Cwerman-Thibault; José-Alain Sahel; Marisol Corral-Debrinski
Journal:  J Inherit Metab Dis       Date:  2010-06-23       Impact factor: 4.982

Review 2.  Delivery of drugs and macromolecules to mitochondria.

Authors:  Abhijit Mukhopadhyay; Henry Weiner
Journal:  Adv Drug Deliv Rev       Date:  2007-06-28       Impact factor: 15.470

3.  Simulation-based cheminformatic analysis of organelle-targeted molecules: lysosomotropic monobasic amines.

Authors:  Xinyuan Zhang; Nan Zheng; Gus R Rosania
Journal:  J Comput Aided Mol Des       Date:  2008-03-13       Impact factor: 3.686

Review 4.  From serendipity to mitochondria-targeted nanocarriers.

Authors:  Volkmar Weissig
Journal:  Pharm Res       Date:  2011-08-11       Impact factor: 4.200

5.  Expression of GFP in the mitochondrial compartment using DQAsome-mediated delivery of an artificial mini-mitochondrial genome.

Authors:  Diana Lyrawati; Alan Trounson; David Cram
Journal:  Pharm Res       Date:  2011-08-11       Impact factor: 4.200

6.  DNA delivery to mitochondria: sequence specificity and energy enhancement.

Authors:  Noha Ibrahim; Hirokazu Handa; Anne Cosset; Milana Koulintchenko; Yuri Konstantinov; Robert N Lightowlers; André Dietrich; Frédérique Weber-Lotfi
Journal:  Pharm Res       Date:  2011-07-12       Impact factor: 4.200

7.  Import of desired nucleic acid sequences using addressing motif of mitochondrial ribosomal 5S-rRNA for fluorescent in vivo hybridization of mitochondrial DNA and RNA.

Authors:  Jaroslav Zelenka; Lukáš Alán; Martin Jabůrek; Petr Ježek
Journal:  J Bioenerg Biomembr       Date:  2014-02-23       Impact factor: 2.945

Review 8.  Novel therapeutic approaches for Leber's hereditary optic neuropathy.

Authors:  Shilpa Iyer
Journal:  Discov Med       Date:  2013-03       Impact factor: 2.970

9.  Re-engineering the mitochondrial genomes in mammalian cells.

Authors:  Young Geol Yoon; Michael D Koob; Young Hyun Yoo
Journal:  Anat Cell Biol       Date:  2010-06-30

10.  Novel HPMA copolymer-bound constructs for combined tumor and mitochondrial targeting.

Authors:  Vaikunth Cuchelkar; Pavla Kopecková; Jindrich Kopecek
Journal:  Mol Pharm       Date:  2008-09-04       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.